This study examines the evolution of Alzheimer's disease (AD)-related patho
logy in a subcortical predilection site, the basal nucleus of Meynert (bnM)
, which is a major source of cortical cholinergic innervation. Brains of 51
autopsy cases were studied using silver techniques and immunostaining for
tau-associated neurofibrillary pathology and for amyloid beta protein (A be
ta) deposits. All cases are classified according to a procedure permitting
differentiation of six stages of AD-related neurofibrillary changes in the
cerebral cortex. Initial cytoskeletal abnormalities in the bnM are already
noted in stage I of cortical neurofibrillary changes. The gradual developme
nt of the neurofibrillary pathology in the bnM parallels the progression of
the AD-related stages in the cerebral cortex. A variety of morphologically
distinguishable cytoskeletal alterations are observed in large nerve cells
which predominate in the bnM. Based on these cellular alterations, a seque
nce of cytoskeletal deterioration is proposed. Initially, the abnormal tau
protein is distributed diffusely throughout the cell body and the neuronal
processes. Subsequently, it aggregates to form a neurofibrillary tangle, wh
ich appears as a spherical somatic inclusion. The cell processes gradually
become fragmented. Finally the parent cell dies, leaving behind an extraneu
ronal "ghost tangle". With regard to the cortical stages of AD-related neur
ofibrillary changes, the initial forms of cytoskeletal changes in the bnM p
redominate in the transentorhinal AD stages (I and II), while "ghost tangle
s" preferentially occur in the neocortical stages (V and VI). The considera
ble morphological diversity of cytoskeletal alterations is typical of stage
s III and IV. These results indicate that individual neurons of the bnM ent
er the sequence of cytoskeletal deterioration at different times.